{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:56:26Z","timestamp":1790704586107,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10741-020-10067-5","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:56:57Z","timestamp":1610492217000},"page":"749-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Device-based treatment options for heart failure with preserved ejection fraction"],"prefix":"10.1007","volume":"26","author":[{"given":"Chihiro","family":"Miyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid H.","family":"Karimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-8416","authenticated-orcid":false,"given":"Kiyotaka","family":"Fukamachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"issue":"6","key":"10067_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tcm.2018.01.001","volume":"28","author":"A Xanthopoulos","year":"2018","unstructured":"Xanthopoulos A, Triposkiadis F, Starling RC (2018) Heart failure with preserved ejection fraction: classification based upon phenotype is essential for diagnosis and treatment. Trends Cardiovasc Med 28(6):392\u2013400. https:\/\/doi.org\/10.1016\/j.tcm.2018.01.001","journal-title":"Trends Cardiovasc Med"},{"issue":"16","key":"10067_CR2","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147-239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10067_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejheart.2006.10.012","volume":"9","author":"EF Lewis","year":"2007","unstructured":"Lewis EF, Lamas GA, O\u2019Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, Pfeffer MA (2007) Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail 9(1):83\u201391. https:\/\/doi.org\/10.1016\/j.ejheart.2006.10.012","journal-title":"Eur J Heart Fail"},{"key":"10067_CR4","doi-asserted-by":"publisher","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37 (27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","DOI":"10.1093\/eurheartj\/ehw128"},{"issue":"30","key":"10067_CR5","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","volume":"39","author":"CSP Lam","year":"2018","unstructured":"Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ (2018) Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J 39(30):2780\u20132792. https:\/\/doi.org\/10.1093\/eurheartj\/ehy301","journal-title":"Eur Heart J"},{"issue":"3","key":"10067_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355(3):251\u2013259. https:\/\/doi.org\/10.1056\/NEJMoa052256","journal-title":"N Engl J Med"},{"issue":"1","key":"10067_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ejhf.30","volume":"16","author":"VM van Deursen","year":"2014","unstructured":"van Deursen VM, Urso R, Laroche C, Damman K, Dahlstrom U, Tavazzi L, Maggioni AP, Voors AA (2014) Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16(1):103\u2013111. https:\/\/doi.org\/10.1002\/ejhf.30","journal-title":"Eur J Heart Fail"},{"key":"10067_CR8","first-page":"19","volume":"17","author":"R De Rosa","year":"2017","unstructured":"De Rosa R, Piscione F, Schranz D, Citro R, Iesu S, Galasso G (2017) Transcatheter implantable devices to monitoring of elevated left atrial pressures in patients with chronic heart failure. Transl Med UniSa 17:19\u201321","journal-title":"Transl Med UniSa"},{"issue":"9","key":"10067_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/circulationaha.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA (2018) A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 138(9):861\u2013870. https:\/\/doi.org\/10.1161\/circulationaha.118.034646","journal-title":"Circulation"},{"issue":"1","key":"10067_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2211-4122.199064","volume":"27","author":"O Issa","year":"2017","unstructured":"Issa O, Peguero JG, Podesta C, Diaz D, De La Cruz J, Pirela D, Brenes JC (2017) Left atrial size and heart failure hospitalization in patients with diastolic dysfunction and preserved ejection fraction. J Cardiovasc Echogr 27(1):1\u20136. https:\/\/doi.org\/10.4103\/2211-4122.199064","journal-title":"J Cardiovasc Echogr"},{"issue":"23","key":"10067_CR11","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/circulationaha.110.011031","volume":"124","author":"MR Zile","year":"2011","unstructured":"Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124(23):2491\u20132501. https:\/\/doi.org\/10.1161\/circulationaha.110.011031","journal-title":"Circulation"},{"issue":"9","key":"10067_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","volume":"76","author":"YNV Reddy","year":"2020","unstructured":"Reddy YNV, Obokata M, Verbrugge FH, Lin G, Borlaug BA (2020) Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. J Am Coll Cardiol 76(9):1051\u20131064. https:\/\/doi.org\/10.1016\/j.jacc.2020.07.009","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10067_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/eurjhf\/hfr066","volume":"13","author":"GC Linssen","year":"2011","unstructured":"Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ (2011) Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 13(10):1111\u20131120. https:\/\/doi.org\/10.1093\/eurjhf\/hfr066","journal-title":"Eur J Heart Fail"},{"key":"10067_CR14","doi-asserted-by":"publisher","unstructured":"Beltrami M, Palazzuoli A, Padeletti L, Cerbai E, Coiro S, Emdin M, Marcucci R, Morrone D, Cameli M, Savino K, Pedrinelli R, Ambrosio G (2018) The importance of integrated left atrial evaluation: from hypertension to heart failure with preserved ejection fraction. Int J Clin Pract 72 (2). https:\/\/doi.org\/10.1111\/ijcp.13050","DOI":"10.1111\/ijcp.13050"},{"issue":"4","key":"10067_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ejhf.976","volume":"20","author":"E Wolsk","year":"2018","unstructured":"Wolsk E, Kaye D, Borlaug BA, Burkhoff D, Kitzman DW, Komtebedde J, Lam CSP, Ponikowski P, Shah SJ, Gustafsson F (2018) Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 20(4):715\u2013722. https:\/\/doi.org\/10.1002\/ejhf.976","journal-title":"Eur J Heart Fail"},{"issue":"44","key":"10067_CR16","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/eurheartj\/ehu315","volume":"35","author":"S Dorfs","year":"2014","unstructured":"Dorfs S, Zeh W, Hochholzer W, Jander N, Kienzle RP, Pieske B, Neumann FJ (2014) Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction. Eur Heart J 35(44):3103\u20133112. https:\/\/doi.org\/10.1093\/eurheartj\/ehu315","journal-title":"Eur Heart J"},{"issue":"4","key":"10067_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jchf.2014.10.011","volume":"3","author":"D Burkhoff","year":"2015","unstructured":"Burkhoff D, Maurer MS, Joseph SM, Rogers JG, Birati EY, Rame JE, Shah SJ (2015) Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. JACC Heart Fail 3(4):275\u2013282. https:\/\/doi.org\/10.1016\/j.jchf.2014.10.011","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10067_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13239-018-00398-8","volume":"10","author":"M Granegger","year":"2019","unstructured":"Granegger M, Dave H, Knirsch W, Thamsen B, Schweiger M, H\u00fcbler M (2019) A valveless pulsatile pump for the treatment of heart failure with preserved ejection fraction: a simulation study. Cardiovasc Eng Technol 10(1):69\u201379. https:\/\/doi.org\/10.1007\/s13239-018-00398-8","journal-title":"Cardiovasc Eng Technol"},{"issue":"1","key":"10067_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcard.2011.01.081","volume":"155","author":"M Fu","year":"2012","unstructured":"Fu M, Zhou J, Sun A, Zhang S, Zhang C, Zou Y, Fu M, Ge J (2012) Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction\u2013a meta analysis of 7 prospective clinical studies. Int J Cardiol 155(1):33\u201338. https:\/\/doi.org\/10.1016\/j.ijcard.2011.01.081","journal-title":"Int J Cardiol"},{"issue":"23","key":"10067_CR20","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456\u20132467. https:\/\/doi.org\/10.1056\/NEJMoa0805450","journal-title":"N Engl J Med"},{"issue":"3","key":"10067_CR21","doi-asserted-by":"publisher","first-page":"e90555","DOI":"10.1371\/journal.pone.0090555","volume":"9","author":"F Liu","year":"2014","unstructured":"Liu F, Chen Y, Feng X, Teng Z, Yuan Y, Bin J (2014) Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis. PLoS ONE 9(3):e90555. https:\/\/doi.org\/10.1371\/journal.pone.0090555","journal-title":"PLoS ONE"},{"issue":"2","key":"10067_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10741-018-9679-y","volume":"23","author":"KO Bonsu","year":"2018","unstructured":"Bonsu KO, Arunmanakul P, Chaiyakunapruk N (2018) Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison. Heart Fail Rev 23(2):147\u2013156. https:\/\/doi.org\/10.1007\/s10741-018-9679-y","journal-title":"Heart Fail Rev"},{"issue":"11","key":"10067_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"issue":"17","key":"10067_CR24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, D\u00fcngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP (2019) Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609\u20131620. https:\/\/doi.org\/10.1056\/NEJMoa1908655","journal-title":"N Engl J Med"},{"issue":"4","key":"10067_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380(4):347\u2013357. https:\/\/doi.org\/10.1056\/NEJMoa1812389","journal-title":"N Engl J Med"},{"issue":"1","key":"10067_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-019-0985-z","volume":"19","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Soga F, Tatsumi K, Mochizuki Y, Sano H, Toki H, Matsumoto K, Shite J, Takaoka H, Doi T, Hirata KI (2020) Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure. Cardiovasc Diabetol 19(1):6. https:\/\/doi.org\/10.1186\/s12933-019-0985-z","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10067_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10741-019-09787-0","volume":"24","author":"A Burlacu","year":"2019","unstructured":"Burlacu A, Simion P, Nistor I, Covic A, Tinica G (2019) Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review. Heart Fail Rev 24(5):793\u2013803. https:\/\/doi.org\/10.1007\/s10741-019-09787-0","journal-title":"Heart Fail Rev"},{"issue":"10","key":"10067_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11886-018-1027-2","volume":"20","author":"A Gupta","year":"2018","unstructured":"Gupta A, Bailey SR (2018) Update on devices for diastolic dysfunction: options for a no option condition? Curr Cardiol Rep 20(10):85. https:\/\/doi.org\/10.1007\/s11886-018-1027-2","journal-title":"Curr Cardiol Rep"},{"key":"10067_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcvm.2019.00143","volume":"6","author":"DM Kaye","year":"2019","unstructured":"Kaye DM, Nanayakkara S (2019) Interatrial shunt device for heart failure with preserved ejection fraction. Front Cardiovasc Med 6:143. https:\/\/doi.org\/10.3389\/fcvm.2019.00143","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10067_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cardfail.2014.01.005","volume":"20","author":"D Kaye","year":"2014","unstructured":"Kaye D, Shah SJ, Borlaug BA, Gustafsson F, Komtebedde J, Kubo S, Magnin C, Maurer MS, Feldman T, Burkhoff D (2014) Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure. J Card Fail 20(3):212\u2013221. https:\/\/doi.org\/10.1016\/j.cardfail.2014.01.005","journal-title":"J Card Fail"},{"issue":"7","key":"10067_CR31","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ejhf.111","volume":"16","author":"L S\u00f8ndergaard","year":"2014","unstructured":"S\u00f8ndergaard L, Reddy V, Kaye D, Malek F, Walton A, Mates M, Franzen O, Neuzil P, Ihlemann N, Gustafsson F (2014) Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail 16(7):796\u2013801. https:\/\/doi.org\/10.1002\/ejhf.111","journal-title":"Eur J Heart Fail"},{"issue":"10025","key":"10067_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/s0140-6736(16)00704-2","volume":"387","author":"G Hasenfu\u00df","year":"2016","unstructured":"Hasenfu\u00df G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der Heyden J, Lang I, Petrie MC, Cleland JG, Leon M, Kaye DM (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 387(10025):1298\u20131304. https:\/\/doi.org\/10.1016\/s0140-6736(16)00704-2","journal-title":"Lancet"},{"issue":"12","key":"10067_CR33","doi-asserted-by":"publisher","first-page":"e003662","DOI":"10.1161\/circheartfailure.116.003662","volume":"9","author":"DM Kaye","year":"2016","unstructured":"Kaye DM, Hasenfu\u00df G, Neuzil P, Post MC, Doughty R, Trochu JN, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Walton A, Muller D, Walters D, Hausleiter J, Raake P, Petrie MC, Bergmann M, Jondeau G, Feldman T, Veldhuisen DJ, Ponikowski P, Silvestry FE, Burkhoff D, Hayward C (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circ Heart Fail 9(12):e003662. https:\/\/doi.org\/10.1161\/circheartfailure.116.003662","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10067_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/circulationaha.117.032094","volume":"137","author":"T Feldman","year":"2018","unstructured":"Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ (2018) Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [reduce elevated left atrial pressure in patients with heart failure]): a phase 2, randomized. Sham-controlled trial Circulation 137(4):364\u2013375. https:\/\/doi.org\/10.1161\/circulationaha.117.032094","journal-title":"Sham-controlled trial Circulation"},{"issue":"8","key":"10067_CR35","doi-asserted-by":"publisher","first-page":"e004540","DOI":"10.1161\/circheartfailure.117.004540","volume":"11","author":"J Wessler","year":"2018","unstructured":"Wessler J, Kaye D, Gustafsson F, Petrie MC, Hasenfu\u03b2 G, Lam CSP, Borlaug BA, Komtebedde J, Feldman T, Shah SJ, Burkhoff D (2018) Impact of baseline hemodynamics on the effects of a transcatheter interatrial shunt device in heart failure with preserved ejection fraction. Circ Heart Fail 11(8):e004540. https:\/\/doi.org\/10.1161\/circheartfailure.117.004540","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10067_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ehf2.12350","volume":"6","author":"DM Kaye","year":"2019","unstructured":"Kaye DM, Petrie MC, McKenzie S, Hasenfu\u03b2 G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C (2019) Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Fail 6(1):62\u201369. https:\/\/doi.org\/10.1002\/ehf2.12350","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10067_CR37","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1001\/jamacardio.2018.2936","volume":"3","author":"SJ Shah","year":"2018","unstructured":"Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L (2018) One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) Trial: a randomized clinical trial. JAMA Cardiol 3(10):968\u2013977. https:\/\/doi.org\/10.1001\/jamacardio.2018.2936","journal-title":"JAMA Cardiol"},{"issue":"12","key":"10067_CR38","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.amjcard.2019.09.019","volume":"124","author":"TC Hanff","year":"2019","unstructured":"Hanff TC, Kaye DM, Hayward CS, Post MC, Malek F, Hasenfu\u03b2 G, Gustafsson F, Burkhoff D, Shah SJ, Litwin SE, Kahwash R, Hummel SL, Borlaug BA, Solomon SD, Lam CSP, Komtebedde J, Silvestry FE (2019) Assessment of predictors of left atrial volume response to a transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial). Am J Cardiol 124(12):1912\u20131917. https:\/\/doi.org\/10.1016\/j.amjcard.2019.09.019","journal-title":"Am J Cardiol"},{"key":"10067_CR39","doi-asserted-by":"publisher","unstructured":"Amat-Santos IJ, Nombela-Franco L, Garc\u00eda B, Tobar J, Rod\u00e9s-Cabau J, San Rom\u00e1n JA (2015) The V-Wave Device f for the treatment of heart failure. Initial experience in Europe. Rev Esp Cardiol (Engl Ed) 68(9):808\u2013810. https:\/\/doi.org\/10.1016\/j.rec.2015.04.015","DOI":"10.1016\/j.rec.2015.04.015"},{"issue":"9","key":"10067_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.4244\/eijy14m05_07","volume":"10","author":"IJ Amat-Santos","year":"2015","unstructured":"Amat-Santos IJ, Bergeron S, Bernier M, Allende R, Barbosa Ribeiro H, Urena M, Pibarot P, Verheye S, Keren G, Yaacoby M, Nitzan Y, Abraham WT, Rod\u00e9s-Cabau J (2015) Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device. EuroIntervention 10(9):1127\u20131131. https:\/\/doi.org\/10.4244\/eijy14m05_07","journal-title":"EuroIntervention"},{"issue":"22","key":"10067_CR41","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.jcin.2018.07.001","volume":"11","author":"J Rod\u00e9s-Cabau","year":"2018","unstructured":"Rod\u00e9s-Cabau J, Bernier M, Amat-Santos IJ, Ben Gal T, Nombela-Franco L, Garc\u00eda Del Blanco B, Kerner A, Bergeron S, Del Trigo M, Pibarot P, Shkurovich S, Eigler N, Abraham WT (2018) Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-Wave System. JACC Cardiovasc Interv 11(22):2300\u20132310. https:\/\/doi.org\/10.1016\/j.jcin.2018.07.001","journal-title":"JACC Cardiovasc Interv"},{"issue":"10025","key":"10067_CR42","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/s0140-6736(16)00585-7","volume":"387","author":"M Del Trigo","year":"2016","unstructured":"Del Trigo M, Bergeron S, Bernier M, Amat-Santos IJ, Puri R, Campelo-Parada F, Altisent OA, Regueiro A, Eigler N, Rozenfeld E, Pibarot P, Abraham WT, Rod\u00e9s-Cabau J (2016) Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study. Lancet 387(10025):1290\u20131297. https:\/\/doi.org\/10.1016\/s0140-6736(16)00585-7","journal-title":"Lancet"},{"issue":"6","key":"10067_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4244\/eijy15m07_08","volume":"11","author":"MB Patel","year":"2015","unstructured":"Patel MB, Samuel BP, Girgis RE, Parlmer MA, Vettukattil JJ (2015) Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension. EuroIntervention 11(6):706\u2013709. https:\/\/doi.org\/10.4244\/eijy15m07_08","journal-title":"EuroIntervention"},{"issue":"7","key":"10067_CR44","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ccd.27233","volume":"90","author":"R Rajeshkumar","year":"2017","unstructured":"Rajeshkumar R, Pavithran S, Sivakumar K, Vettukattil JJ (2017) Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv 90(7):1145\u20131153. https:\/\/doi.org\/10.1002\/ccd.27233","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"10067_CR45","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1161\/circulationaha.118.036460","volume":"138","author":"M Borggrefe","year":"2018","unstructured":"Borggrefe M, Mann DL (2018) Cardiac contractility modulation in 2018. Circulation 138(24):2738\u20132740. https:\/\/doi.org\/10.1161\/circulationaha.118.036460","journal-title":"Circulation"},{"key":"10067_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijcard.2015.10.208","volume":"203","author":"C Tsch\u00f6pe","year":"2016","unstructured":"Tsch\u00f6pe C, Van Linthout S, Spillmann F, Klein O, Biewener S, Remppis A, Gutterman D, Linke WA, Pieske B, Hamdani N, Roser M (2016) Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF. Int J Cardiol 203:1061\u20131066. https:\/\/doi.org\/10.1016\/j.ijcard.2015.10.208","journal-title":"Int J Cardiol"},{"issue":"6","key":"10067_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10741-016-9571-6","volume":"21","author":"F Abi-Samra","year":"2016","unstructured":"Abi-Samra F, Gutterman D (2016) Cardiac contractility modulation: a novel approach for the treatment of heart failure. Heart Fail Rev 21(6):645\u2013660. https:\/\/doi.org\/10.1007\/s10741-016-9571-6","journal-title":"Heart Fail Rev"},{"issue":"8","key":"10067_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/eurheartj\/ehn020","volume":"29","author":"MM Borggrefe","year":"2008","unstructured":"Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, Misier AR, Curnis A, B\u00f6cker D, Remppis A, Kautzner J, St\u00fchlinger M, Leclerq C, T\u00e1borsky M, Frigerio M, Parides M, Burkhoff D, Hindricks G (2008) Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 29(8):1019\u20131028. https:\/\/doi.org\/10.1093\/eurheartj\/ehn020","journal-title":"Eur Heart J"},{"key":"10067_CR49","doi-asserted-by":"publisher","unstructured":"Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Abraham WT (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 161 (2):329\u2013337.e321\u2013322. https:\/\/doi.org\/10.1016\/j.ahj.2010.10.025","DOI":"10.1016\/j.ahj.2010.10.025"},{"issue":"10","key":"10067_CR50","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","volume":"6","author":"WT Abraham","year":"2018","unstructured":"Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfu\u00df G (2018) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail 6(10):874\u2013883. https:\/\/doi.org\/10.1016\/j.jchf.2018.04.010","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10067_CR51","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/eurjhf\/hfs078","volume":"14","author":"M Borggrefe","year":"2012","unstructured":"Borggrefe M, Burkhoff D (2012) Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur J Heart Fail 14(7):703\u2013712. https:\/\/doi.org\/10.1093\/eurjhf\/hfs078","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10067_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.echo.2011.02.004","volume":"24","author":"DA Morris","year":"2011","unstructured":"Morris DA, Gailani M, Vaz P\u00e9rez A, Blaschke F, Dietz R, Haverkamp W, Ozcelik C (2011) Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. J Am Soc Echocardiogr 24(6):651\u2013662. https:\/\/doi.org\/10.1016\/j.echo.2011.02.004","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10067_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/eurjhf\/hfs014","volume":"14","author":"AH Maass","year":"2012","unstructured":"Maass AH, Van Gelder IC (2012) Atrial resynchronization therapy: a new concept for treatment of heart failure with preserved ejection fraction and prevention of atrial fibrillation? Eur J Heart Fail 14(3):227\u2013229. https:\/\/doi.org\/10.1093\/eurjhf\/hfs014","journal-title":"Eur J Heart Fail"},{"key":"10067_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijcard.2017.12.042","volume":"257","author":"S Liu","year":"2018","unstructured":"Liu S, Guan Z, Zheng X, Meng P, Wang Y, Li Y, Zhang Y, Yang J, Jia D, Ma C (2018) Impaired left atrial systolic function and inter-atrial dyssynchrony may contribute to symptoms of heart failure with preserved left ventricular ejection fraction: a comprehensive assessment by echocardiography. Int J Cardiol 257:177\u2013181. https:\/\/doi.org\/10.1016\/j.ijcard.2017.12.042","journal-title":"Int J Cardiol"},{"issue":"11","key":"10067_CR55","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1111\/j.1540-8159.1997.tb05433.x","volume":"20","author":"C Daubert","year":"1997","unstructured":"Daubert C, Leclercq C, Le Breton H, Gras D, Pavin D, Pouvreau Y, Van Verooij P, Bakels N, Mabo P (1997) Permanent left atrial pacing with a specifically designed coronary sinus lead. Pacing Clin Electrophysiol 20(11):2755\u20132764. https:\/\/doi.org\/10.1111\/j.1540-8159.1997.tb05433.x","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10067_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/eurjhf\/hfs150","volume":"15","author":"G Laurent","year":"2013","unstructured":"Laurent G, Eicher JC, Mathe A, Bertaux G, Barthez O, Debin R, Billard C, Philip JL, Wolf JE (2013) Permanent left atrial pacing therapy may improve symptoms in heart failure patients with preserved ejection fraction and atrial dyssynchrony: a pilot study prior to a national clinical research programme. Eur J Heart Fail 15(1):85\u201393. https:\/\/doi.org\/10.1093\/eurjhf\/hfs150","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10067_CR57","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/CRD.0b013e3181f87921","volume":"19","author":"MM Ng","year":"2011","unstructured":"Ng MM, Sica DA, Frishman WH (2011) Rheos: an implantable carotid sinus stimulation device for the nonpharmacologic treatment of resistant hypertension. Cardiol Rev 19(2):52\u201357. https:\/\/doi.org\/10.1097\/CRD.0b013e3181f87921","journal-title":"Cardiol Rev"},{"issue":"2","key":"10067_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2008.09.034","volume":"53","author":"MT La Rovere","year":"2009","unstructured":"La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, Sleight P, Febo O (2009) Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 53(2):193\u2013199. https:\/\/doi.org\/10.1016\/j.jacc.2008.09.034","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10067_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cardfail.2013.11.007","volume":"20","author":"K Funakoshi","year":"2014","unstructured":"Funakoshi K, Hosokawa K, Kishi T, Ide T, Sunagawa K (2014) Striking volume intolerance is induced by mimicking arterial baroreflex failure in normal left ventricular function. J Card Fail 20(1):53\u201359. https:\/\/doi.org\/10.1016\/j.cardfail.2013.11.007","journal-title":"J Card Fail"},{"issue":"6","key":"10067_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, M\u00fcller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC (2015) Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail 3(6):487\u2013496. https:\/\/doi.org\/10.1016\/j.jchf.2015.02.006","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10067_CR61","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","volume":"36","author":"JK Kirklin","year":"2017","unstructured":"Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB, Naftel DC (2017) Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 36(10):1080\u20131086. https:\/\/doi.org\/10.1016\/j.healun.2017.07.005","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10067_CR62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/circheartfailure.110.959288","volume":"4","author":"Y Topilsky","year":"2011","unstructured":"Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ (2011) Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 4(3):266\u2013275. https:\/\/doi.org\/10.1161\/circheartfailure.110.959288","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10067_CR63","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1540-8191.2011.01331.x","volume":"26","author":"E Wynne","year":"2011","unstructured":"Wynne E, Bergin JD, Ailawadi G, Kern JA, Kennedy JL (2011) Use of a left ventricular assist device in hypertrophic cardiomyopathy. J Card Surg 26(6):663\u2013665. https:\/\/doi.org\/10.1111\/j.1540-8191.2011.01331.x","journal-title":"J Card Surg"},{"issue":"2","key":"10067_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MAT.0b013e318286018d","volume":"59","author":"K Muthiah","year":"2013","unstructured":"Muthiah K, Phan J, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Granger E, Dhital K, Spratt P, Jansz P, Hayward CS (2013) Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy: a case series. Asaio j 59(2):183\u2013187. https:\/\/doi.org\/10.1097\/MAT.0b013e318286018d","journal-title":"Asaio j"},{"issue":"5","key":"10067_CR65","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/eurjhf\/hfq006","volume":"12","author":"LH Lund","year":"2010","unstructured":"Lund LH, Matthews J, Aaronson K (2010) Patient selection for left ventricular assist devices. Eur J Heart Fail 12(5):434\u2013443. https:\/\/doi.org\/10.1093\/eurjhf\/hfq006","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10067_CR66","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jtcvs.2012.06.057","volume":"145","author":"F Moscato","year":"2013","unstructured":"Moscato F, Wirrmann C, Granegger M, Eskandary F, Zimpfer D, Schima H (2013) Use of continuous flow ventricular assist devices in patients with heart failure and a normal ejection fraction: a computer-simulation study. J Thorac Cardiovasc Surg 145(5):1352\u20131358. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.06.057","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10067_CR67","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s10439-020-02492-2","volume":"48","author":"A Escher","year":"2020","unstructured":"Escher A, Choi Y, Callaghan F, Thamsen B, Kertzscher U, Schweiger M, H\u00fcbler M, Granegger M (2020) A valveless pulsatile pump for heart failure with preserved ejection fraction: hemo- and fluid dynamic feasibility. Ann Biomed Eng 48(6):1821\u20131836. https:\/\/doi.org\/10.1007\/s10439-020-02492-2","journal-title":"Ann Biomed Eng"},{"issue":"10","key":"10067_CR68","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.medengphy.2011.05.008","volume":"33","author":"GA Giridharan","year":"2011","unstructured":"Giridharan GA, Lederer C, Berthe A, Goubergrits L, Hutzenlaub J, Slaughter MS, Dowling RD, Spence PA, Koenig SC (2011) Flow dynamics of a novel counterpulsation device characterized by CFD and PIV modeling. Med Eng Phys 33(10):1193\u20131202. https:\/\/doi.org\/10.1016\/j.medengphy.2011.05.008","journal-title":"Med Eng Phys"},{"issue":"1","key":"10067_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jtcvs.2006.07.037","volume":"133","author":"D Morley","year":"2007","unstructured":"Morley D, Litwak K, Ferber P, Spence P, Dowling R, Meyns B, Griffith B, Burkhoff D (2007) Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg 133(1):21\u201328. https:\/\/doi.org\/10.1016\/j.jtcvs.2006.07.037","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10067_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2019.12.110","author":"K Fukamachi","year":"2020","unstructured":"Fukamachi K, Horvath DJ, Karimov JH, Kado Y, Miyamoto T, Kuban BD, Starling RC (2020) Left atrial assist device to treat patients with heart failure with preserved ejection fraction: initial in vitro study. J Thorac Cardiovasc Surg. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.12.110","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"10067_CR71","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ejhf.147","volume":"16","author":"AB Santos","year":"2014","unstructured":"Santos AB, Kraigher-Krainer E, Gupta DK, Claggett B, Zile MR, Pieske B, Voors AA, Lefkowitz M, Bransford T, Shi V, Packer M, McMurray JJ, Shah AM, Solomon SD (2014) Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail 16(10):1096\u20131103. https:\/\/doi.org\/10.1002\/ejhf.147","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10067_CR72","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jacc.2006.08.062","volume":"49","author":"H Persson","year":"2007","unstructured":"Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, Ostergren J, McKelvie RS (2007) Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 49(6):687\u2013694. https:\/\/doi.org\/10.1016\/j.jacc.2006.08.062","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10067_CR73","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jchf.2019.11.006","volume":"8","author":"EP Zeitler","year":"2020","unstructured":"Zeitler EP, Abraham WT (2020) Novel devices in heart failure: BAT, Atrial Shunts, and Phrenic Nerve Stimulation. JACC Heart Fail 8(4):251\u2013264. https:\/\/doi.org\/10.1016\/j.jchf.2019.11.006","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10067_CR74","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ejhf.497","volume":"18","author":"JM Ter Maaten","year":"2016","unstructured":"Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, van Heerebeek L, Hillege HL, Lam CS, Navis G, Voors AA (2016) Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18(6):588\u2013598. https:\/\/doi.org\/10.1002\/ejhf.497","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10067_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/circulationaha.116.021884","volume":"134","author":"SJ Shah","year":"2016","unstructured":"Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, Paulus WJ (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134(1):73\u201390. https:\/\/doi.org\/10.1161\/circulationaha.116.021884","journal-title":"Circulation"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-10067-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T05:29:19Z","timestamp":1621920559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-10067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10067"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10067-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"8 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"Kiyotaka Fukamachi, Jamshid H. Karimov, and Randall C. Starling are co-inventors of the LAAD. The other coauthors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}